Advertisement

Topics

UPDATE 1-Swiss biotech firm AC Immune increases IPO size

06:19 EDT 23 Sep 2016 | Reuters

ZURICH, Sept 23 (Reuters) - AC Immune, the Swiss biotech company working on treating Alzheimer's disease, has boosted the size of its initial public offering (IPO) to raise nearly $58 million it needs to continue research on its products.

Original Article: UPDATE 1-Swiss biotech firm AC Immune increases IPO size

NEXT ARTICLE

More From BioPortfolio on "UPDATE 1-Swiss biotech firm AC Immune increases IPO size"

Quick Search
Advertisement
 

Relevant Topics

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Neurology - Central Nervous System (CNS)
Alzheimer's Disease Anesthesia Anxiety Disorders Autism Bipolar Disorders Dementia Epilepsy Multiple Sclerosis (MS) Neurology Pain Parkinson's Disease Sleep Disorders Neurology is the branch of me...